Aged – Page 2 – HCV Guidance

Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C

June 16, 2017
Loss of hepatitis C virus RNA after parturition in female patients with chronic HCV infection

June 16, 2017
Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention

June 16, 2017
Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents

June 5, 2017
Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent

May 23, 2017
Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection

May 23, 2017
Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection

May 23, 2017
Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network

May 23, 2017
Predictors of poor mental and physical health status among patients with chronic hepatitis C infection: the chronic hepatitis cohort study (CHeCS)

May 23, 2017
Effects of viral eradication with ledipasvir and sofosbuvir, with or without ribavirin, on measures of fatigue in patients with chronic hepatitis C virus infection

May 18, 2017